Birth control method choice and use of barrier methods for sexually transmitted disease prevention among low-income African-American women.
In a prospective study of 1122 women attending a sexually transmitted disease (STD) clinic in Alabama, consistent use of the male condom and vaginal microbicide/spermicides was promoted to reduce STD risk. This analysis evaluated: 1) baseline characteristics that may influence birth control method choice; and 2) the association of birth control method and other baseline characteristics with consistency of barrier use during follow up. Birth control method was associated with sociodemographic variables, sexual, and reproductive history. Women who adopted user-independent methods (tubal ligation, implants, injectable hormones) appear to have completed their family plan. Oral contraceptive users were of higher socioeconomic status and at lower STD risk. Barrier method users and women who used no method were young and at higher STD risk. Consistency of condom/spermicide use increased in all groups. Barrier method users were more likely than other women to use condoms and spermicides during the study. Women who used no birth control method at baseline experienced the largest increase in barrier use during follow up, although their barrier use rates were lower than in other groups. The synergism between the intention to prevent pregnancy and the intention to prevent STD should be considered in the design of interventions promoting condom use.
Macaluso
M
M
Department of Epidemiology and International Health, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA. mmacalus@uab.edu
Cheng
H
H
Akers
R
R
D000293:Adolescent; D000328:Adult; D001741:Black or African American; D000407:Alabama; D003267:Contraception; D003274:Contraceptive Devices, Female; D005260:Female; D006801:Humans; D007434:Intrauterine Devices; D016912:Levonorgestrel; D008297:Male; D017258:Medroxyprogesterone Acetate; D010298:Parity; D011247:Pregnancy; D012725:Sexual Behavior; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*; D012959:Socioeconomic Factors; D013246:Sterilization, Tubal
D016912:Levonorgestrel; D017258:Medroxyprogesterone Acetate